1. 127P Phase I study of fianlimab: A human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced NSCLC. (December 2022) Authors: Cho, B.C.; Dy, G.; Kim, T.M.; Sarker, D.; Hamid, O.; Williamson, S.; Sang-We, K.; Hatim, H.; Chen, S.; Mani, J.; Jankovic, V.; Paccaly, A.J.; Masinde, S.; Lowy, I.; Brennan, L.; Gullo, G. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 150P Phase I study of fianlimab: A human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma (mel) - Subgroup analysis. (December 2022) Authors: Hamid, O.; Lewis, K.; Weise, A.; McKean, M.; Papadopoulos, K.; Crown, J.P.; Thomas, S.; Kaczmar, J.; Lakhani, N.; Kim, T.M.; Kim, K.; Rabinowits, G.; Spira, A.S.; Mani, J.; Chen, S.; Gullo, G. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 187P Phase I/II study of the oral CCR4 antagonist, FLX475, as monotherapy and in combination with pembrolizumab in advanced cancer. (December 2022) Authors: Lin, C-C.; Kim, T.M.; Desai, P.; Lee, K.H.; Feng, Y-H.; Ngamphaiboon, N.; Kim, S-B.; Yang, M-H.; Muzaffar, J.; Chmielowski, B.; Swiecicki, P.L.; Bowyer, S.E.; Brahmer, J.R.; Chisamore, M.; Goyal, R.; Nasrah, N.; Ho, W.; Cho, B.C. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Acquired resistance mechanisms to INC280, a MET inhibitor in MET-amplified lung cancer cells. (December 2016) Authors: Kim, S.; Kim, T.M.; Kim, D.W.; Kim, S.; Kim, M.; Ahn, Y.O.; Keam, B.; Heo, D.S. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Diagnostic accuracy of the jetting sign and a dilatation ratio of left renal vein in CT urography for detecting anterior nutcracker syndrome. Issue 7 (July 2021) Authors: Kim, T.M.; Cho, J.Y.; Kim, S.Y.; Kim, S.H. Journal: Clinical radiology Issue: Volume 76:Issue 7(2021) Page Start: 510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Mechanisms of resistance to mobocertinib in EGFR exon 20 insertion-mutant non-small cell lung cancer (NSCLC). (October 2022) Authors: Park, S.; Kim, T.M.; Kim, S.; Kim, M.; Keam, B.; Kim, D.W.; Heo, D.S. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. MO-0721 Clinicogenomic predictors for the pattern of failure in high-grade glioma. (May 2022) Authors: Kang, B.; Lee, J.H.; Kim, T.M.; Won, J.; Yun, H.; Choi, S.H.; Lee, S.; Park, S.; Park, C. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-0623: Impact of Interim Events during the Surgery-to-Radiotherapy Interval in Newly Diagnosed Glioblastoma. (May 2017) Authors: Wee, C.W.; Kim, E.; Kim, I.H.; Kim, T.M.; Park, C.K.; Kim, J.W.; Choi, S.H. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-1002: Comparison of Best Commercial Model and Atlas based segmentation with CT and MR in brain cancer. (May 2017) Authors: Woo, J.Y.; Kim, T.Y.; Seok, J.Y.; Kim, T.M.; Cho, Y.W.; Kim, S.Y.; Baek, J.G.; Kim, J.H.; Cho, J.H. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB OR OBINUTUZUMAB IN RELAPSED/REFRACTORY FL OR DLBCL: UPDATED RESULTS OF A PHASE 1B/2 STUDY. (June 2017) Authors: Matasar, M.; Herrera, A.F.; Kamdar, M.; Mehta, A.; Assouline, S.; Fleury, I.; Kim, T.M.; Kim, W.S.; Bosch, F.; Radford, J.; Flowers, C.R.; Bu, L.; Hong, W.; Sehn, L.H. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗